Everolimus(RAD001)
11 Inquiries
159351-69-6
99%
2026-08-08
Coenzymes,Inhibito,Enzymes,Zymogens,Substrates,Native Microorganism Creatine Amidinohydrolase
-
Product Description
-
Seller Information
-
Inquiry History
-
DescriptionCreative Enzymes, with approximately 65811 visits to its shop, is a reputable Manufactory that has been providing Everolimus(RAD001) products for 6 years on ECHEMI.Basic Info
-
Product Name:
Everolimus
Other Name:Rapamycin,42-O-(2-hydroxyethyl)-;23,27-Epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclohentriacontine,rapamycin deriv.;42-O-(2-Hydroxyethyl)rapamycin;40-O-(2-Hydroxyethyl)rapamycin;SDZ-RAD;RAD 001;Everolimus;RAD;Certican;XIENCE V;Afinitor;Zortress;Xience;Afinitor Disperz;Votubia;1245613-55-1;2413306-61-1
CAS No.:159351-69-6
Molecular Formula:C53H83NO14
InChIKeys:InChIKey=HKVAMNSJSFKALM-GKUWKFKPSA-N
Molecular Weight:958.232
Exact Mass:958.22
EC Number:1806241-263-5
DSSTox ID:DTXSID0040599
HScode:29349990
Categories:
Characteristics-
PSA:
205 Ų
Density:1.18±0.1 g/cm3(Predicted)
Melting Point:No melting point
Boiling Point:998.7±75.0 °C(Predicted)
Flash Point:2℃
Refractive Index:1.548
Water Solubility:Soluble in dimethysulfoxide,ethanol and chloroform. Slightly soluble in water.
Storage Conditions:−20°C
Hazard IdentificationClassification of the substance or mixture
Specific target organ toxicity â repeated exposure, Category 1
GHS label elements, including precautionary statements
Pictogram(s) 
Signal word Danger
Hazard statement(s) H372 Causes damage to organs through prolonged or repeated exposure
Precautionary statement(s) Prevention P260 Do not breathe dust/fume/gas/mist/vapours/spray.
P264 Wash ... thoroughly after handling.
P270 Do not eat, drink or smoke when using this product.
Response P319 Get medical help if you feel unwell.
Storage none
Disposal P501 Dispose of contents/container to an appropriate treatment and disposal facility in accordance with applicable laws and regulations, and product characteristics at time of disposal.
Other hazards which do not result in classification
no data available
Handling and StoragePrecautions for safe handling
Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.
Conditions for safe storage, including any incompatibilities
Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.
-
-
Seller Information
-
Business Type:
Manufactory
-
Main Products:
Coenzymes,Inhibito,Enzymes,Zymogens,Substrates,Native Microorganism Creatine Amidinohydrolase
-
Location:
Shirley, New York 11967, USA
-
Payment Terms:
TT against copy of documents,D/P
-
Average lead Time:
15
-
Total Annual Revenue:
$1 million-$2.5 million
-
Year of Establishment:
2004
-
-
Inquiry History11 Inquiries
Country Product Purchase Quantity Date Posted 
Spain
Factory Supply Everolimus 99% 159351-69-6 raw Everolimus Powder with Fast Delivery
1 MT Oct 5, 2023 
India
Everolimus
50 G Jun 29, 2026
India
Everolimus
25 G Jul 17, 2025 
Russia
Everolimus API
1 KG Jul 10, 2025 
United Kingdom
everolimus
1 KG Mar 22, 2025
India
Everolimus
15 G Sep 27, 2024
Spain
Everolimus 0,2% BHT
2 MT Dec 22, 2023
India
Everolimus
50.00 G Jul 2, 2026 
United States
Everolimus
25 G Jan 26, 2026 
Pakistan
Everolimus
1 KG Sep 26, 2025
Pakistan
Everolimus
1 G Nov 7, 2024 Post an enquiry for this product